LivaNova PLC (NASDAQ: LIVN) Stock Competitors & Peer Comparison
See LIVN's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for LIVN and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| LIVN | $76.99 | -0.28% | 4.2B | 18.29 | $4.21 | N/A |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| ABT | $100.94 | -0.04% | 174.7B | 19.37 | $5.21 | +2.46% |
| MDT | $87.12 | -2.66% | 111.5B | 15.75 | $5.53 | +3.22% |
| SYK | $278.86 | +1.29% | 106.9B | 20.83 | $13.39 | +1.27% |
| BSX | $43.85 | -0.59% | 65.2B | 14.15 | $3.10 | N/A |
| EW | $88.11 | +1.47% | 50.7B | 32.63 | $2.70 | N/A |
| DXCM | $86.64 | -0.05% | 32.7B | 33.98 | $2.55 | N/A |
| GEHC | $66.46 | -0.48% | 30B | 14.57 | $4.56 | +0.21% |
| PHG | $24.77 | -1.35% | 24.2B | 14.15 | $1.75 | +3.94% |
Stock Comparison
Boston Scientific Corporation (NYSE: BSX-PA)
LIVN vs BSX-PA Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, LIVN's ROE is +0.15%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, LIVN is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check BSX-PA's competition here
Abbott Laboratories (NYSE: ABT)
LIVN vs ABT Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, ABT has a market cap of 174.7B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while ABT trades at $100.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas ABT's P/E ratio is 19.37. In terms of profitability, LIVN's ROE is +0.15%, compared to ABT's ROE of +0.11%. Regarding short-term risk, LIVN is less volatile compared to ABT. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check ABT's competition here
Medtronic plc (NYSE: MDT)
LIVN vs MDT Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, MDT has a market cap of 111.5B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while MDT trades at $87.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas MDT's P/E ratio is 15.75. In terms of profitability, LIVN's ROE is +0.15%, compared to MDT's ROE of +0.11%. Regarding short-term risk, LIVN is less volatile compared to MDT. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
LIVN vs SYK Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, SYK has a market cap of 106.9B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while SYK trades at $278.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas SYK's P/E ratio is 20.83. In terms of profitability, LIVN's ROE is +0.15%, compared to SYK's ROE of +0.16%. Regarding short-term risk, LIVN is less volatile compared to SYK. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
LIVN vs BSX Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, BSX has a market cap of 65.2B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while BSX trades at $43.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas BSX's P/E ratio is 14.15. In terms of profitability, LIVN's ROE is +0.15%, compared to BSX's ROE of +0.15%. Regarding short-term risk, LIVN is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
LIVN vs EW Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, EW has a market cap of 50.7B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while EW trades at $88.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas EW's P/E ratio is 32.63. In terms of profitability, LIVN's ROE is +0.15%, compared to EW's ROE of +0.10%. Regarding short-term risk, LIVN is less volatile compared to EW. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
LIVN vs DXCM Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, DXCM has a market cap of 32.7B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while DXCM trades at $86.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas DXCM's P/E ratio is 33.98. In terms of profitability, LIVN's ROE is +0.15%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, LIVN is less volatile compared to DXCM. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
LIVN vs GEHC Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, GEHC has a market cap of 30B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while GEHC trades at $66.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas GEHC's P/E ratio is 14.57. In terms of profitability, LIVN's ROE is +0.15%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, LIVN is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
LIVN vs PHG Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, PHG has a market cap of 24.2B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while PHG trades at $24.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas PHG's P/E ratio is 14.15. In terms of profitability, LIVN's ROE is +0.15%, compared to PHG's ROE of +0.10%. Regarding short-term risk, LIVN is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
LIVN vs ZBH Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, ZBH has a market cap of 17.7B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while ZBH trades at $91.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas ZBH's P/E ratio is 10.77. In terms of profitability, LIVN's ROE is +0.15%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, LIVN is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
LIVN vs ABMD Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas ABMD's P/E ratio is 65.36. In terms of profitability, LIVN's ROE is +0.15%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, LIVN is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check ABMD's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
LIVN vs SWAV Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas SWAV's P/E ratio is 78.76. In terms of profitability, LIVN's ROE is +0.15%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, LIVN is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check SWAV's competition here
Penumbra, Inc. (NYSE: PEN)
LIVN vs PEN Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while PEN trades at $318.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas PEN's P/E ratio is 83.26. In terms of profitability, LIVN's ROE is +0.15%, compared to PEN's ROE of +0.11%. Regarding short-term risk, LIVN is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
LIVN vs SNN Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, SNN has a market cap of 11.3B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while SNN trades at $26.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas SNN's P/E ratio is 18.19. In terms of profitability, LIVN's ROE is +0.15%, compared to SNN's ROE of +0.12%. Regarding short-term risk, LIVN is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check SNN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
LIVN vs BIO-B Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, BIO-B has a market cap of 10.5B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while BIO-B trades at $385.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas BIO-B's P/E ratio is -67.89. In terms of profitability, LIVN's ROE is +0.15%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, LIVN is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check BIO-B's competition here
Align Technology, Inc. (NASDAQ: ALGN)
LIVN vs ALGN Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, ALGN has a market cap of 10.3B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while ALGN trades at $144.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas ALGN's P/E ratio is 13.13. In terms of profitability, LIVN's ROE is +0.15%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, LIVN is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
LIVN vs BIO Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, BIO has a market cap of 10.2B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while BIO trades at $379.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas BIO's P/E ratio is 40.90. In terms of profitability, LIVN's ROE is +0.15%, compared to BIO's ROE of +0.03%. Regarding short-term risk, LIVN is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check BIO's competition here
Globus Medical, Inc. (NYSE: GMED)
LIVN vs GMED Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, GMED has a market cap of 10.2B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while GMED trades at $75.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas GMED's P/E ratio is 17.06. In terms of profitability, LIVN's ROE is +0.15%, compared to GMED's ROE of +0.12%. Regarding short-term risk, LIVN is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check GMED's competition here
Bruker Corporation (NASDAQ: BRKR)
LIVN vs BRKR Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, BRKR has a market cap of 9.8B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while BRKR trades at $64.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas BRKR's P/E ratio is 32.42. In terms of profitability, LIVN's ROE is +0.15%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, LIVN is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
LIVN vs BRKRP Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, BRKRP has a market cap of 9.5B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while BRKRP trades at $472.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas BRKRP's P/E ratio is 256.72. In terms of profitability, LIVN's ROE is +0.15%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, LIVN is less volatile compared to BRKRP. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check BRKRP's competition here
Masimo Corporation (NASDAQ: MASI)
LIVN vs MASI Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas MASI's P/E ratio is 44.43. In terms of profitability, LIVN's ROE is +0.15%, compared to MASI's ROE of +0.09%. Regarding short-term risk, LIVN is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check MASI's competition here
Glaukos Corporation (NYSE: GKOS)
LIVN vs GKOS Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, GKOS has a market cap of 9.4B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while GKOS trades at $158.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas GKOS's P/E ratio is -184.34. In terms of profitability, LIVN's ROE is +0.15%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, LIVN is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check GKOS's competition here
Insulet Corp. (NASDAQ: PODD)
LIVN vs PODD Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, PODD has a market cap of 9.2B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while PODD trades at $132.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas PODD's P/E ratio is 22.63. In terms of profitability, LIVN's ROE is +0.15%, compared to PODD's ROE of +0.27%. Regarding short-term risk, LIVN is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check PODD's competition here
Haemonetics Corporation (NYSE: HAE)
LIVN vs HAE Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, HAE has a market cap of 4.8B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while HAE trades at $105.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas HAE's P/E ratio is 21.13. In terms of profitability, LIVN's ROE is +0.15%, compared to HAE's ROE of +0.11%. Regarding short-term risk, LIVN is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
LIVN vs NARI Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas NARI's P/E ratio is -59.24. In terms of profitability, LIVN's ROE is +0.15%, compared to NARI's ROE of -0.00%. Regarding short-term risk, LIVN is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
LIVN vs ITGR Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while ITGR trades at $126.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas ITGR's P/E ratio is 19.90. In terms of profitability, LIVN's ROE is +0.15%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, LIVN is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check ITGR's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
LIVN vs IRTC Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, IRTC has a market cap of 3.8B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while IRTC trades at $114.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas IRTC's P/E ratio is -265.63. In terms of profitability, LIVN's ROE is +0.15%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, LIVN is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
LIVN vs AXNX Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas AXNX's P/E ratio is -709.80. In terms of profitability, LIVN's ROE is +0.15%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, LIVN is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
LIVN vs TMDX Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, TMDX has a market cap of 2.9B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while TMDX trades at $84.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas TMDX's P/E ratio is 42.68. In terms of profitability, LIVN's ROE is +0.15%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, LIVN is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check TMDX's competition here
Neogen Corporation (NASDAQ: NEOG)
LIVN vs NEOG Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, NEOG has a market cap of 2.8B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while NEOG trades at $12.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas NEOG's P/E ratio is 45.46. In terms of profitability, LIVN's ROE is +0.15%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, LIVN is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check NEOG's competition here
Butterfly Network, Inc. (NYSE: BFLY)
LIVN vs BFLY Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, BFLY has a market cap of 2.4B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while BFLY trades at $9.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas BFLY's P/E ratio is -37.90. In terms of profitability, LIVN's ROE is +0.15%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, LIVN is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check BFLY's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
LIVN vs UFPT Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, UFPT has a market cap of 2.3B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while UFPT trades at $296.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas UFPT's P/E ratio is 30.33. In terms of profitability, LIVN's ROE is +0.15%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, LIVN is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check UFPT's competition here
AxoGen, Inc. (NASDAQ: AXGN)
LIVN vs AXGN Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, AXGN has a market cap of 2.3B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while AXGN trades at $42.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas AXGN's P/E ratio is 111.68. In terms of profitability, LIVN's ROE is +0.15%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, LIVN is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check AXGN's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
LIVN vs INSP Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, INSP has a market cap of 2.1B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while INSP trades at $73.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas INSP's P/E ratio is 32.26. In terms of profitability, LIVN's ROE is +0.15%, compared to INSP's ROE of +0.18%. Regarding short-term risk, LIVN is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check INSP's competition here
NuVasive, Inc. (NASDAQ: NUVA)
LIVN vs NUVA Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas NUVA's P/E ratio is 75.00. In terms of profitability, LIVN's ROE is +0.15%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, LIVN is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check NUVA's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
LIVN vs ESTA Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, ESTA has a market cap of 1.9B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while ESTA trades at $63.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas ESTA's P/E ratio is -50.56. In terms of profitability, LIVN's ROE is +0.15%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, LIVN is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check ESTA's competition here
Novocure Ltd (NASDAQ: NVCR)
LIVN vs NVCR Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, NVCR has a market cap of 1.9B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while NVCR trades at $15.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas NVCR's P/E ratio is -12.30. In terms of profitability, LIVN's ROE is +0.15%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, LIVN is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check NVCR's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
LIVN vs ATEC Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, ATEC has a market cap of 1.6B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while ATEC trades at $10.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas ATEC's P/E ratio is -172.83. In terms of profitability, LIVN's ROE is +0.15%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, LIVN is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
LIVN vs CNMD Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, CNMD has a market cap of 1.4B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while CNMD trades at $46.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas CNMD's P/E ratio is 10.26. In terms of profitability, LIVN's ROE is +0.15%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, LIVN is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
LIVN vs HSKA Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas HSKA's P/E ratio is -62.49. In terms of profitability, LIVN's ROE is +0.15%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, LIVN is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
LIVN vs IART Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while IART trades at $16.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas IART's P/E ratio is 7.05. In terms of profitability, LIVN's ROE is +0.15%, compared to IART's ROE of -0.01%. Regarding short-term risk, LIVN is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check IART's competition here
Avanos Medical, Inc. (NYSE: AVNS)
LIVN vs AVNS Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas AVNS's P/E ratio is 27.77. In terms of profitability, LIVN's ROE is +0.15%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, LIVN is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check AVNS's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
LIVN vs TNDM Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, TNDM has a market cap of 1.1B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while TNDM trades at $16.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas TNDM's P/E ratio is -17.82. In terms of profitability, LIVN's ROE is +0.15%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, LIVN is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check TNDM's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
LIVN vs SILK Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas SILK's P/E ratio is -18.96. In terms of profitability, LIVN's ROE is +0.15%, compared to SILK's ROE of -0.35%. Regarding short-term risk, LIVN is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check SILK's competition here
Artivion, Inc. (NYSE: AORT)
LIVN vs AORT Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, AORT has a market cap of 1.1B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while AORT trades at $22.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas AORT's P/E ratio is 38.07. In terms of profitability, LIVN's ROE is +0.15%, compared to AORT's ROE of -0.01%. Regarding short-term risk, LIVN is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check AORT's competition here
IRadimed Corporation (NASDAQ: IRMD)
LIVN vs IRMD Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while IRMD trades at $86.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas IRMD's P/E ratio is 43.45. In terms of profitability, LIVN's ROE is +0.15%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, LIVN is less volatile compared to IRMD. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check IRMD's competition here
Paragon 28, Inc. (NYSE: FNA)
LIVN vs FNA Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas FNA's P/E ratio is -19.83. In terms of profitability, LIVN's ROE is +0.15%, compared to FNA's ROE of -0.35%. Regarding short-term risk, LIVN is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check FNA's competition here
Enovis Corporation (NYSE: ENOV)
LIVN vs ENOV Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, ENOV has a market cap of 1.1B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while ENOV trades at $18.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas ENOV's P/E ratio is 5.29. In terms of profitability, LIVN's ROE is +0.15%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, LIVN is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check ENOV's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
LIVN vs PRCT Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, PRCT has a market cap of 1B. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while PRCT trades at $18.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas PRCT's P/E ratio is -9.39. In terms of profitability, LIVN's ROE is +0.15%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, LIVN is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check PRCT's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
LIVN vs LMRI Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, LMRI has a market cap of 985.8M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while LMRI trades at $10.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas LMRI's P/E ratio is -19.96. In terms of profitability, LIVN's ROE is +0.15%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, LIVN is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check LMRI's competition here
Bioventus Inc. (NASDAQ: BVS)
LIVN vs BVS Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, BVS has a market cap of 948.5M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while BVS trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas BVS's P/E ratio is 18.42. In terms of profitability, LIVN's ROE is +0.15%, compared to BVS's ROE of +0.28%. Regarding short-term risk, LIVN is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
LIVN vs CBLL Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, CBLL has a market cap of 943.3M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while CBLL trades at $24.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas CBLL's P/E ratio is -14.12. In terms of profitability, LIVN's ROE is +0.15%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, LIVN is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check CBLL's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
LIVN vs BBNX Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, BBNX has a market cap of 873.2M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while BBNX trades at $19.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas BBNX's P/E ratio is -11.76. In terms of profitability, LIVN's ROE is +0.15%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, LIVN is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check BBNX's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
LIVN vs SIBN Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, SIBN has a market cap of 849.3M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while SIBN trades at $19.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas SIBN's P/E ratio is -56.32. In terms of profitability, LIVN's ROE is +0.15%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, LIVN is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check SIBN's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
LIVN vs CSII Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, CSII has a market cap of 844M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas CSII's P/E ratio is -20.83. In terms of profitability, LIVN's ROE is +0.15%, compared to CSII's ROE of -0.14%. Regarding short-term risk, LIVN is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check CSII's competition here
InMode Ltd. (NASDAQ: INMD)
LIVN vs INMD Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, INMD has a market cap of 817.4M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while INMD trades at $14.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas INMD's P/E ratio is 9.88. In terms of profitability, LIVN's ROE is +0.15%, compared to INMD's ROE of +0.12%. Regarding short-term risk, LIVN is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check INMD's competition here
Varex Imaging Corporation (NASDAQ: VREX)
LIVN vs VREX Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, VREX has a market cap of 777.6M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while VREX trades at $18.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas VREX's P/E ratio is 19.44. In terms of profitability, LIVN's ROE is +0.15%, compared to VREX's ROE of +0.05%. Regarding short-term risk, LIVN is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check VREX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
LIVN vs AHCO Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, AHCO has a market cap of 771.4M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while AHCO trades at $5.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas AHCO's P/E ratio is 11.57. In terms of profitability, LIVN's ROE is +0.15%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, LIVN is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check AHCO's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
LIVN vs CTKB Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, CTKB has a market cap of 743.9M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while CTKB trades at $5.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas CTKB's P/E ratio is -30.51. In terms of profitability, LIVN's ROE is +0.15%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, LIVN is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check CTKB's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
LIVN vs AVR Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, AVR has a market cap of 738M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while AVR trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas AVR's P/E ratio is -3.91. In terms of profitability, LIVN's ROE is +0.15%, compared to AVR's ROE of -0.78%. Regarding short-term risk, LIVN is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check AVR's competition here
Surmodics, Inc. (NASDAQ: SRDX)
LIVN vs SRDX Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas SRDX's P/E ratio is -34.66. In terms of profitability, LIVN's ROE is +0.15%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, LIVN is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check SRDX's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
LIVN vs KIDS Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, KIDS has a market cap of 584.6M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while KIDS trades at $22.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas KIDS's P/E ratio is -19.29. In terms of profitability, LIVN's ROE is +0.15%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, LIVN is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check KIDS's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
LIVN vs APEN Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas APEN's P/E ratio is -9.43. In terms of profitability, LIVN's ROE is +0.15%, compared to APEN's ROE of -0.85%. Regarding short-term risk, LIVN is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check APEN's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
LIVN vs SSII Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, SSII has a market cap of 578.4M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while SSII trades at $2.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas SSII's P/E ratio is -48.17. In terms of profitability, LIVN's ROE is +0.15%, compared to SSII's ROE of -0.27%. Regarding short-term risk, LIVN is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check SSII's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
LIVN vs PACB Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, PACB has a market cap of 568.4M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while PACB trades at $1.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas PACB's P/E ratio is -4.46. In terms of profitability, LIVN's ROE is +0.15%, compared to PACB's ROE of -49.62%. Regarding short-term risk, LIVN is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check PACB's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
LIVN vs DCTH Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, DCTH has a market cap of 547.2M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while DCTH trades at $15.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas DCTH's P/E ratio is 1585.00. In terms of profitability, LIVN's ROE is +0.15%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, LIVN is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
LIVN vs ZIMV Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, LIVN's ROE is +0.15%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, LIVN is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check ZIMV's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
LIVN vs SGHT Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, SGHT has a market cap of 508.7M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while SGHT trades at $9.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas SGHT's P/E ratio is -16.70. In terms of profitability, LIVN's ROE is +0.15%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, LIVN is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check SGHT's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
LIVN vs TCMD Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, TCMD has a market cap of 508.2M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while TCMD trades at $22.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas TCMD's P/E ratio is 20.86. In terms of profitability, LIVN's ROE is +0.15%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, LIVN is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check TCMD's competition here
Cerus Corporation (NASDAQ: CERS)
LIVN vs CERS Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, CERS has a market cap of 497.8M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while CERS trades at $2.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas CERS's P/E ratio is -82.06. In terms of profitability, LIVN's ROE is +0.15%, compared to CERS's ROE of -0.10%. Regarding short-term risk, LIVN is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check CERS's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
LIVN vs NPCE Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, NPCE has a market cap of 475.3M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while NPCE trades at $13.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas NPCE's P/E ratio is -24.46. In terms of profitability, LIVN's ROE is +0.15%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, LIVN is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check NPCE's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
LIVN vs SENS Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, SENS has a market cap of 420M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while SENS trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas SENS's P/E ratio is -4.51. In terms of profitability, LIVN's ROE is +0.15%, compared to SENS's ROE of -1.66%. Regarding short-term risk, LIVN is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
LIVN vs OFIX Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, OFIX has a market cap of 394.1M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while OFIX trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas OFIX's P/E ratio is -6.35. In terms of profitability, LIVN's ROE is +0.15%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, LIVN is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check OFIX's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
LIVN vs CLPT Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, CLPT has a market cap of 353M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while CLPT trades at $11.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas CLPT's P/E ratio is -9.97. In terms of profitability, LIVN's ROE is +0.15%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, LIVN is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check CLPT's competition here
CapsoVision, Inc. (NASDAQ: CV)
LIVN vs CV Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, CV has a market cap of 334.3M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while CV trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas CV's P/E ratio is -10.62. In terms of profitability, LIVN's ROE is +0.15%, compared to CV's ROE of -1.78%. Regarding short-term risk, LIVN is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check CV's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
LIVN vs SMLR Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas SMLR's P/E ratio is 3.92. In terms of profitability, LIVN's ROE is +0.15%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, LIVN is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
LIVN vs TMCI Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, TMCI has a market cap of 299.7M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while TMCI trades at $4.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas TMCI's P/E ratio is -4.91. In terms of profitability, LIVN's ROE is +0.15%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, LIVN is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check TMCI's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
LIVN vs CATX Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, CATX has a market cap of 298.8M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while CATX trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas CATX's P/E ratio is -1.97. In terms of profitability, LIVN's ROE is +0.15%, compared to CATX's ROE of -0.42%. Regarding short-term risk, LIVN is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check CATX's competition here
Avita Medical Inc. (NASDAQ: RCEL)
LIVN vs RCEL Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, RCEL has a market cap of 297.1M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while RCEL trades at $11.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas RCEL's P/E ratio is -8.31. In terms of profitability, LIVN's ROE is +0.15%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, LIVN is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check RCEL's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
LIVN vs INFU Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, INFU has a market cap of 263M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while INFU trades at $13.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas INFU's P/E ratio is 31.78. In terms of profitability, LIVN's ROE is +0.15%, compared to INFU's ROE of +0.15%. Regarding short-term risk, LIVN is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check INFU's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
LIVN vs TLSI Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, TLSI has a market cap of 261.7M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while TLSI trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas TLSI's P/E ratio is -2.53. In terms of profitability, LIVN's ROE is +0.15%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, LIVN is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check TLSI's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
LIVN vs MGRM Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas MGRM's P/E ratio is -12.00. In terms of profitability, LIVN's ROE is +0.15%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, LIVN is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check MGRM's competition here
Electromed, Inc. (AMEX: ELMD)
LIVN vs ELMD Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, ELMD has a market cap of 232.9M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while ELMD trades at $28.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas ELMD's P/E ratio is 21.47. In terms of profitability, LIVN's ROE is +0.15%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, LIVN is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
LIVN vs NVRO Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas NVRO's P/E ratio is -1.91. In terms of profitability, LIVN's ROE is +0.15%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, LIVN is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check NVRO's competition here
Profound Medical Corp. (NASDAQ: PROF)
LIVN vs PROF Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, PROF has a market cap of 207.9M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while PROF trades at $5.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas PROF's P/E ratio is -5.84. In terms of profitability, LIVN's ROE is +0.15%, compared to PROF's ROE of -0.56%. Regarding short-term risk, LIVN is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check PROF's competition here
RxSight, Inc. (NASDAQ: RXST)
LIVN vs RXST Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, RXST has a market cap of 197.5M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while RXST trades at $4.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas RXST's P/E ratio is -4.22. In terms of profitability, LIVN's ROE is +0.15%, compared to RXST's ROE of -0.17%. Regarding short-term risk, LIVN is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check RXST's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
LIVN vs BSGM Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas BSGM's P/E ratio is -5.81. In terms of profitability, LIVN's ROE is +0.15%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, LIVN is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check BSGM's competition here
Quantum-Si incorporated (NASDAQ: QSI)
LIVN vs QSI Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, QSI has a market cap of 189.5M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while QSI trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas QSI's P/E ratio is -2.08. In terms of profitability, LIVN's ROE is +0.15%, compared to QSI's ROE of -0.47%. Regarding short-term risk, LIVN is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check QSI's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
LIVN vs MDGS Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas MDGS's P/E ratio is -0.27. In terms of profitability, LIVN's ROE is +0.15%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, LIVN is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check MDGS's competition here
Quanterix Corporation (NASDAQ: QTRX)
LIVN vs QTRX Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, QTRX has a market cap of 172.9M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while QTRX trades at $3.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas QTRX's P/E ratio is -1.44. In terms of profitability, LIVN's ROE is +0.15%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, LIVN is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check QTRX's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
LIVN vs FOCL Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, FOCL has a market cap of 170.2M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while FOCL trades at $4.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas FOCL's P/E ratio is -4.39. In terms of profitability, LIVN's ROE is +0.15%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, LIVN is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check FOCL's competition here
Neuronetics, Inc. (NASDAQ: STIM)
LIVN vs STIM Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, STIM has a market cap of 164.2M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while STIM trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas STIM's P/E ratio is -5.36. In terms of profitability, LIVN's ROE is +0.15%, compared to STIM's ROE of -1.51%. Regarding short-term risk, LIVN is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check STIM's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
LIVN vs QIPT Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas QIPT's P/E ratio is -15.87. In terms of profitability, LIVN's ROE is +0.15%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, LIVN is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check QIPT's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
LIVN vs LUCD Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, LUCD has a market cap of 154.3M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while LUCD trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas LUCD's P/E ratio is -2.19. In terms of profitability, LIVN's ROE is +0.15%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, LIVN is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check LUCD's competition here
Inogen, Inc. (NASDAQ: INGN)
LIVN vs INGN Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, INGN has a market cap of 145.4M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while INGN trades at $5.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas INGN's P/E ratio is -5.90. In terms of profitability, LIVN's ROE is +0.15%, compared to INGN's ROE of -0.13%. Regarding short-term risk, LIVN is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check INGN's competition here
iCAD, Inc. (NASDAQ: ICAD)
LIVN vs ICAD Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas ICAD's P/E ratio is -20.37. In terms of profitability, LIVN's ROE is +0.15%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, LIVN is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check ICAD's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
LIVN vs HJLI Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas HJLI's P/E ratio is N/A. In terms of profitability, LIVN's ROE is +0.15%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, LIVN is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check HJLI's competition here
electroCore, Inc. (NASDAQ: ECOR)
LIVN vs ECOR Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, ECOR has a market cap of 98.1M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while ECOR trades at $10.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas ECOR's P/E ratio is -6.48. In terms of profitability, LIVN's ROE is +0.15%, compared to ECOR's ROE of +5.25%. Regarding short-term risk, LIVN is less volatile compared to ECOR. This indicates lower risk in terms of short-term price fluctuations for LIVN.Check ECOR's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
LIVN vs ASXC Comparison September 2026
LivaNova PLC (NASDAQ: LIVN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LIVN stands at 4.2B. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, LIVN is priced at $76.99 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LIVN currently has a P/E ratio of 18.29, whereas ASXC's P/E ratio is -1.12. In terms of profitability, LIVN's ROE is +0.15%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, LIVN is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for LIVN.Check ASXC's competition here